1089-80-1 Usage
Uses
Used in Pharmaceutical Industry:
1,3,5(10), 9(11)-ESTRATETRAEN-3-OL-17-ONE is used as a pharmaceutical compound for its potential role in hormone regulation and treatment of hormone-related conditions. As a metabolite of 17β-Estradiol, it may have implications in the treatment of conditions related to estrogen levels, such as menopause, osteoporosis, and certain types of cancer.
Used in Research and Development:
In the field of research and development, 1,3,5(10), 9(11)-ESTRATETRAEN-3-OL-17-ONE is used as a key compound for studying the structure-activity relationships of steroidal hormones. This understanding can lead to the development of new drugs with improved efficacy and reduced side effects.
Used in Quality Control and Impurity Testing:
As an impurity of Ethynyl Estradiol (E685100), 1,3,5(10), 9(11)-ESTRATETRAEN-3-OL-17-ONE is used in quality control and impurity testing for pharmaceutical products containing Ethynyl Estradiol. Ensuring the purity and safety of these products is crucial for their effectiveness and patient safety.
Used in Endocrine Disruption Studies:
Given its structural similarity to Estrone and 17β-Estradiol, 1,3,5(10), 9(11)-ESTRATETRAEN-3-OL-17-ONE can be used in endocrine disruption studies to understand the effects of environmental chemicals on hormone regulation and their potential impact on human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 1089-80-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,8 and 9 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1089-80:
(6*1)+(5*0)+(4*8)+(3*9)+(2*8)+(1*0)=81
81 % 10 = 1
So 1089-80-1 is a valid CAS Registry Number.
1089-80-1Relevant articles and documents
A new route to 19-substituted steroids from 19-nor steroids: Sigmatropic [3,3] and [2,3] rearrangements revisited
Lesuisse,Canu,Tric
, p. 8491 - 8504 (2007/10/02)
Sigmatropic [3,3] and [2,3] rearrangements of 11-substituted estradienedione derivatives gave rise to new 19-substituted androstenedione analogs.